Results 241 to 250 of about 72,813 (290)

Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A. [PDF]

Pharmaceutics
Mahadeo A, Tsang YP, Zheng AR, Arnzen S, Rodriguez AG, Warren MS, Gáborik Z, Kelly EJ.   +7 more
europepmc   +1 more source

Epithelial-mesenchymal transition and sunitinib resistance in renal cell carcinoma: mechanisms and therapeutic strategies. [PDF]

Front Pharmacol
Zhang M, Zhang Y, Shen F, Yan M, Cheng P, Teng J, Zou M, Yao W, Wang Z, Li W.   +9 more
europepmc   +1 more source

Genome-wide association studies and traditional Chinese medicine in hyperuricemia: current evidence and mechanistic insights. [PDF]

Front Pharmacol
Yang L, Liu J, Luo S, Deng Y.
europepmc   +1 more source

Copper-Induced Cell Death in Renal Diseases: Molecular Mechanisms and Therapeutic Implications. [PDF]

Drug Des Devel Ther
Lv D, Yu Y.
europepmc   +1 more source

Personalized pharmacokinetic-pharmacodynamic guided therapy via an induced pluripotent stem cell-derived multi-organoid platform in NF1-mutant breast cancer. [PDF]

Signal Transduct Target Ther
Lim JH, Mun SJ, Kang HM, Yu WD, Oh SJ, Lee JY, Son YS, Lee S, Kim DS, Lee J, Kim SJ, Cho HS, Son MJ, Son MY, Jung CR.   +14 more
europepmc   +1 more source

Characterization of renal cationic drug transport with amantadine

, 1992
openaire   +1 more source

Renal Transporters in Drug Development [PDF]

Annual Review of Pharmacology and Toxicology, 2013
The kidney plays a vital role in the body's defense against potentially toxic xenobiotics and metabolic waste products through elimination pathways. In particular, secretory transporters in the proximal tubule are major determinants of the disposition of xenobiotics, including many prescription drugs.
Sophie L Stocker, Kathleen M Giacomini
exaly   +5 more sources